Area of research
Molecular Biology · Oncology
Research interest
Research interests include HDAC6, Histone deacetylase, Chemistry, Melanoma, HDAC11, and Potency.
Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function
Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation
Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot–Marie–Tooth Disease
Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
Development and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors
Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth